Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer’s Disease
Condition(s):Alzheimer’s DiseaseLast Updated:April 13, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:April 13, 2017Completed
Condition(s):NarcolepsyLast Updated:March 10, 2017Terminated
Condition(s):Mild Cognitive Impairment; DementiaLast Updated:June 4, 2012Completed
Condition(s):HyperalgesiaLast Updated:August 7, 2017Completed
Condition(s):Alzheimer’s DiseaseLast Updated:July 7, 2017Completed
Condition(s):SchizophreniaLast Updated:May 2, 2011Completed
Condition(s):Allergic RhinitisLast Updated:April 16, 2014Completed
Condition(s):SchizophreniaLast Updated:November 8, 2017Completed
Condition(s):Multiple SclerosisLast Updated:July 26, 2017Completed
Condition(s):FatigueLast Updated:June 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.